05UD3JZ
Supplement Cephalic Vein, Right to No Qualifier with Synthetic Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 5 Upper Veins |
| Operation | U Supplement |
| Body Part | D Cephalic Vein, Right |
| Approach | 3 Percutaneous |
| Device | J Synthetic Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures reinforce or augment an upper-body vein that remains anatomically in place by adding biological or synthetic material onto or into it, without removing the vein itself. This is typically done to strengthen a weakened vein wall, widen a narrowed segment with a patch, or add support to a vein used for vascular access so it can better withstand repeated needle sticks or higher blood flow, such as when a dialysis fistula vein is patched to improve its diameter.
Unlike replacement, the patient's own vein tissue is preserved and left functioning; the added material works alongside it rather than substituting for it. This makes Supplement a less invasive option than Replacement when the vein wall is intact enough to be reinforced rather than excised.
Anatomy & Axis Detail
Cephalic Vein, Right
The right cephalic vein travels along the lateral arm and is one of the preferred vessels for arteriovenous fistula creation because of its accessible, superficial position. When this vein develops a weakened or aneurysmal wall segment, often at a prior anastomosis or repeated cannulation site, a supplement procedure adds reinforcing material, such as an autograft patch, to restore structural competence without removing the native vessel. Coders should note that reinforcing a cephalic vein already functioning as fistula outflow differs from initial fistula formation, and the underlying vein tissue must remain in place with added material physically integrated into it. Precise laterality matters here since the right and left cephalic veins are reported with distinct body part values, and documentation should clarify which limb was treated.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Synthetic Substitute
Synthetic Substitute designates a device made from manufactured, non-biologic material, such as mesh or prosthetic components, used to replace or augment a body part. It is distinguished from the two tissue substitute categories by its artificial composition, which carries different considerations for integration and long-term durability than biologic grafts.
Coding & Documentation
Documentation supporting Supplement includes terms like "venoplasty with patch graft," "reinforcement of vein wall," or "angioplasty patch" applied to a named upper vein, with the key detail being that the native vein was not removed. The material used - autologous patch, bovine pericardium, synthetic patch - should be identified because it maps to a specific device or material value in the code.
Coders most often err by defaulting to Replacement whenever graft material is mentioned, without confirming whether the original vein segment was excised (Replacement) or simply reinforced in place (Supplement). Another frequent issue is missing Supplement entirely when a patch angioplasty is performed on a vein during a larger vascular access procedure, since it can be overshadowed in the note by the primary access-creation procedure.